INJ

Injective

TRON, Injective, and XRP moved in different directions over the past day. XRP stayed flat inside a tight range. TRON drifted lower toward oversold levels. Injective broke higher and pushed into overbought territory. This kind of split in the crypto market means each asset is foll...

Altseason indicators not seen since 2020 have reappeared, signaling a potential shift of liquidity from Bitcoin into select altcoins with strong fundamentals. VeChain, Optimism and Injective showcase structural triggers including enterprise integration, Layer-2 growth and deflati...

The H price has been on a quiet tear. Humanity Protocol is up 41% since Monday, quietly cracking the top 100 ranked market caps in crypto. Santiment reports that whale transactions hit a five month high, with 35 large moves over $100,000 each. Network growth also climbed to a two...

Injective has started to show signs of life again after months of quiet price action. The INJ price now trades close to $3.5, and that matters because it comes after a steady recovery from April lows. The token has already climbed more than 30% within a short window, which has sh...

ARB remains bearish, with downside risk below $0.1074 toward all-time low. INJ shows weak momentum, with potential drop below $3.036 toward $2.500. BCH attempts recovery, but must break $574.1 to confirm bullish continuation. The crypto market continues to show mixed signals as A...

Analysts observe that early exchange expansion phases historically coincide with increased retail participation and short-term liquidity-driven price acceleration patterns. Infrastructure-focused altcoins often receive attention before broader accessibility improves across global...

INJ rallies after U.S. Futures launch and supply burn.

Injective (INJ) has recorded a sharp upward move over the past 24 hours, climbing more than 10% to trade above $3.30. By the latest session, INJ peaked around $3.41 before stabilising near $3.35, showing strong intraday demand and elevated trading activity. The token’s sudden strength stood out in an otherwise quiet crypto market, where most major assets were largely flat. The price surge was not random. It came shortly after the launch of US-regulated futures contracts on Bitnomial, a CFTC-regulated exchange. https://twitter.com/injective/status/2044417942423552331?s=20 The launch of US-regulated INJ futures contracts on Bitnomial The introduction of INJ futures on a CFTC-regulated platform marks a meaningful step forward for the asset’s positioning in the broader crypto market. It places Injective alongside a small group of major cryptocurrencies, including Bitcoin (BTC) , Ethereum (ETH), Solana (SOL), and XRP , that already have regulated futures markets in the United States. This matters because regulated futures products open the door to institutional participation in a way that spot markets alone often cannot. Hedge funds, trading firms, and asset managers can now gain exposure to INJ without directly holding the token. That reduces custody friction and expands the range of strategies that can be built around the asset, including hedging and leveraged positioning. More importantly, the launch also begins what many traders refer to as a “track record window.” This is a period where trading activity in regulated futures markets is monitored over time. In practice, this can play a role in strengthening the case for future exchange-traded products, including potential ETF-related structures. INJ price technical analysis Following the ETF news, INJ’s price has broken above its short-term and medium-term moving averages, signalling a shift in momentum after weeks of relatively muted performance. Trading volume has also surged significantly during the move, rising more than 100% above recent averages, suggesting the rally is backed by genuine participation rather than thin liquidity or isolated trading spikes. From a technical perspective, INJ’s strength pushed the Relative Strength Index into the mid-60s range, reflecting a strong momentum without entering overheated territory, which often leaves room for continuation if buying pressure persists. Injective price chart | Source: TradingView At the same time, the price action revealed a clear short-term structure. The $3.20 area has emerged as an important support zone, acting as a key level where buyers have consistently stepped in. On the upside, the $3.41 level has now become an immediate resistance point after being tested during the recent surge. If this level holds, analysts project another attempt to break above $3.41. A successful breakout could open the door toward the next upside area around $3.53, based on commonly tracked technical extensions. On the other hand, a failure to hold the $3.20 support could lead to a retracement back toward the $3.08 region, which would not necessarily invalidate the broader momentum. The post Why is Injective (INJ) surging 10% after US futures launch? appeared first on Invezz

Bitnomial launches US-regulated Injective futures, raising fresh questions about market access, price discovery, and possible ETF implications for INJ. Read original article on coinwy.com